Optical Breast Imaging Developers Seek Light At The End Of The Tunnel
This article was originally published in The Gray Sheet
Executive Summary
The challenges of developing a next-generation breast cancer screening technology that targets tumor vessels has already overwhelmed one company, but others continue to persevere to reach FDA's finish-line